Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing Efficacy and Safety of Telitacicept and Belimumab in Systemic Lupus Erythematosus: A Retrospective Multicenter Cohort Study

NCT07053137 is registered in ClinicalTrials.gov with Yipeng Liu as lead sponsor.

NCT NCT07053137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07053137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing Efficacy and Safety of Telitacicept and Belimumab in Systemic Lupus Erythematosus: A Retrospective Multicenter Cohort Study
Lead sponsor
Yipeng Liu
Phase
Observational
Overall status
Active, not recruiting
Start date
November 30, 2025
Completion date
March 31, 2026
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

belimumab, efficacy and safety, systemic lupus erythematosus, telitacicept